1 Structure and Hierarchy of Influenza Virus Models Revealed by Reaction Network Analysis.

2 seroprevalence of influenza a h1n1 and seroconversion of mothers and infants induced by a single dose of monovalent vaccine

3 Bigger and Better? Representativeness of the Influenza A Surveillance Using One Consolidated Clinical Microbiology Laboratory Data Set as Compared to the Belgian Sentinel Network of Laboratories.

4 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

5 Drug resistance in influenza A virus: the epidemiology and management

6 Post-influenza aspergillosis, do not underestimate influenza B

7 Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

8 Influenza A Viral Infection with Septic Shock in Pregnancy

9 Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

10 Drug resistance in influenza A virus: the epidemiology and management

11 Post-influenza aspergillosis, do not underestimate influenza B

12 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

13 CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

14 Invasive Salmonella Enteritidis infection complicated by bacterial meningitis and vertebral osteomyelitis shortly after influenza A infection in an immunocompetent young adult.

15 THE ORGANIZATION OF HOSPITAL CARE DURING THE EPIDEMIC OF INFLUENZA AND SARS FOR THE 2016 SEASON IN VELIKY NOVGOROD

16 Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity

17 p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.

18 Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases.

19 Interventions for avian influenza A (H5N1) risk management in live bird market networks.

20 Evidence of the Presence of Low Pathogenic Avian Influenza A Viruses in Wild Waterfowl in 2018 in South Africa.

21 Influenza and pneumococcal vaccination uptake in adults aged ≥65 years and high risk groups admitted to yozgat bozok university research and application hospital

22 Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.

23 Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.

24 Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

25 Antiviral activity of extracted fraction from camel urine against corona and influenza a (H1N1) viruses

26 Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins

27 Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice

28 [The Effects and Mechanisms of Dihydroartemisinin on Influenza A Virus H1N1 Induces TNF-α and IL-6 Expression in Bronchial Epithelial Cells].

29 Systemic sclerosis and vaccinations: A register-based cohort study about seasonal influenza and streptococcus pneumoniae vaccination rate and uptake from Liguria regional center, Northwest Italy

30 (-)-Epigallocatechin-3-gallate induces interferon-λ2 expression to anti-influenza A virus in human bronchial epithelial cells (BEAS-2B) through p38 MAPK signaling pathway.

31 Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.

32 Virus Detection and Duration of Illness Among Patients With 2009 Pandemic Influenza A (H1N1) Virus Infection in Texas

33 Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1

34 Antigenicity and Reactogenicity of Influenza A/USSR/77 Virus Vaccine in Children — A Multicentered Evaluation of Dosage and Safety

35 Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults

36 Clinical, Virological, and Histopathological Manifestations of Fatal Human Infections by Avian Influenza A(H7N9) Virus

37 Virus survival as a seasonal factor in influenza and poliomyelitis

38 Maternal influenza and birth outcomes: systematic review of comparative studies

39 Obesity Increases the Duration of Influenza A Virus Shedding in Adults

40 The Current Status of Planning for Pandemic Influenza and Implications for Health Care Planning in the United States

41 Household Transmission of 2009 Pandemic Influenza A (H1N1) and Nonpharmaceutical Interventions among Households of High School Students in San Antonio, Texas

42 Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009

43 Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

44 Lactobacillus plantarum surface-displayed influenza antigens (NP-M2) with FliC flagellin stimulate generally protective immune responses against H9N2 influenza subtypes in chickens.

45 risk assessment of human infection with avian influenza a (h7n9) virus in taiwan

46 immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza a virus

47 molecular characterization of severe and mild cases of influenza a (h1n1) 2009 strain from argentina caracterización molecular de cepas de influenza a (h1n1) 2009 de casos leves y graves de la argentina

48 mutation analysis of the neuraminidase gene of influenza a(h1n1)pdm09 in tunisia between 2009 and 2017 seasons

49 the impact of altitude on hospitalization and hospital mortality from pandemic 2009 influenza a (h1n1) virus pneumonia in mexico el impacto de la altitud en las tasas de hospitalización y mortalidad por el virus de la influenza a (h1n1) pandémico en méxico

50 experimental approaches to study genome packaging of influenza a viruses

51 reacciones adversas a la vacuna contra influenza a (h1n1) en trabajadores de salud de una institución pública peruana

52 perfil epidemiológico de la mortalidad por influenza humana a (h1n1) en méxico epidemiological profile of mortality due to human influenza a (h1n1) in mexico

53 assessment of epicutaneous testing of a monovalent influenza a (h1n1) 2009 vaccine in egg allergic patients

54 modified vaccinia virus ankara (mva) as production platform for vaccines against influenza and other viral respiratory diseases

55 risco de uma pandemia de influenza pelo vírus a (h1n1) the risk of a pandemic with the influenza a (h1n1) virus

56 a case for rimantadine to be marketed in canada for prophylaxis of influenza a virus infection

57 novel avian h7n9 influenza and its way to humans

58 in vivo production of monoclonal antibodies by gene transfer via electroporation protects against lethal influenza and ebola infections

59 seropositivity of influenza a h1ni in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic

60 attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

61 correction: attenuated recombinant influenza a virus expressing hpv16 e6 and e7 as a novel therapeutic vaccine approach.

62 new small-molecule drug design strategies for fighting resistant influenza a

63 risk factors associated with death among influenza a (h1n1) patients, tamil nadu, india, 2010

64 antiviral activity of a nanoemulsion of polyprenols from ginkgo leaves against influenza a h3n2 and hepatitis b virus in vitro

65 vaccination rates for pandemic influenza among pregnant women: an early observation from chennai, south india

66 combined interventions for mitigation of an influenza a (h1n1) 2009 outbreak in a physical training camp in beijing, china

67 karakteristik klinis dan epidemiologis avian influenza a (h5n1) anak di indonesia, tahun 2005-2007

68 influenza and pneumococcal vaccination in long term care facilities in two regions of quebec

69 antiviral drug profile of human influenza a & b viruses circulating in india: 2004-2011

70 treatment of immunocompromised, critically ill patients with influenza a h1n1 infection with a combination of oseltamivir, amantadine, and zanamivir

71 vacinação contra influenza e pneumococo na insuficiência cardíaca: uma recomendação pouco aplicada vacunación contra influenza y neumococo en la insuficiencia cardíaca: una recomendación poco aplicada influenza and pneumococcal vaccination in heart failure: a little applied recommendation

72 is avian influenza a (h7n9) virus staggering its way to humans?

73 influenza a h1n1 de origen porcino: métodos diagnósticos

74 influenza and bacterial pathogen coinfections in the 20th century

75 polymyositis following pandemic influenza a (h1n1) and 2009-10 seasonal trivalent vaccines

76 viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza a(h7n9) virus in zhejiang, china, 2013

77 ns segment of a 1918 influenza a virus-descendent enhances replication of h1n1pdm09 and virus-induced cellular immune response in mammalian and avian systems

78 avian influenza a (h5n1) infection with respiratory failure and meningoencephalitis in a canadian traveller

79 influenza a virus entry: implications in virulence and future therapeutics

80 in vitro anti-viral activity of psoraleae semen water extract against influenza a viruses

81 comparative studies on two tests for detection of avian influenza a virus and newcastle disease virus in co-infected guinea fowl (numida meleagris)

82 amino acid substitution k470r in the nucleoprotein increases the virulence of h5n1 influenza a virus in mammals

83 report of a fatal pediatric case of hemophagocytic lymphohistiocytosis associated with pandemic influenza a (h1n1) infection in 2009

84 san wu huangqin decoction, a chinese herbal formula, inhibits influenza a/pr/8/34 (h1n1) virus infection in vitro and in vivo

85 pandemia de influenza a por nuevo virus h1n1

86 prevalence of influenza a (h1n1) seropositivity in unvaccinated healthcare workers in scotland at the height of the global pandemic

87 knowledge, attitudes, and practices regarding pandemic h1n1 influenza among medical and dental residents and fellowships in shiraz, iran

88 síndrome de guillain-barré em associação temporal com a vacina influenza a guillain-barré syndrome in temporal association with influenza a vaccine

89 an outbreak of influenza among physicians during the first wave of mexico city's 2009 h1n1 epidemic

90 henoch-schönlein purpura following influenza a h1n1 vaccination

91 Awareness of influenza and pneumococcal vaccines in diabetic patients.

92 Impact of Prompt Influenza Antiviral Treatment on Extended Care Needs After Influenza Hospitalization Among Community-Dwelling Older Adults

93 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

94 Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection

95 Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

96 Viral load in patients infected with pandemic H1N1 2009 influenza A virus

97 Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies

98 Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus

99 Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

100 Serial Intervals and the Temporal Distribution of Secondary Infections within Households of 2009 Pandemic Influenza A (H1N1): Implications for Influenza Control Recommendations

101 Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses

Keyword Connections

Journals

Research Groups

Bibliographies